| Patent # | Description |
|---|---|
| US-5,688,965 |
Azabicyclic compounds useful as an intermediate for the preparation of
pyidone carboxylic acid compounds and... Pyridone carboxylic acid compounds and pharmaceutically acceptable salts and physiologically hydrolyzable esters thereof are provided which are represented by... |
| US-5,688,964 |
Process for preparing a acylhyrazino pyrazole derivative A process for making a compound of formula III ##STR1## wherein R.sub.6 is a group bonded to the rest of the molecule by a carbon atom; R.sub.3 is a group... |
| US-5,688,963 |
Intermediates for the preparation of triazolinones The invention relates to a new process and to new intermediates for the preparation of triazolinones, most of which are known, of the general formula (I) ... |
| US-5,688,962 |
Cyclization process for making oxazolikinones A process for the synthesis of a compound of general formula II: ##STR1## wherein: R.sup.2 and R.sup.3 are each independently hydrogen or C.sub.1 -C.sub.4... |
| US-5,688,961 |
Method of manufacturing a silicon-type charge transporting material A method of manufacturing charge transporting materials which impart a charge transporting property to a polysiloxane resin, and which is soluble in the resin.... |
| US-5,688,960 |
Substituted oximes, hydrazones and olefins useful as neurokinin
antagonists Compound represented by the structural formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein: a is 0, 1, 2 or 3; b, d and e are independently... |
| US-5,688,959 |
Photographic color elements Color photographic motion picture elements adapted to form a multicolor photographic dye image and an integral, infrared-absorbing, dye sound track and... |
| US-5,688,958 |
Cationic phospholipids for transfection A novel class of cationic phospholipids and novel method for their synthesis are disclosed. The class of phospholipids comprises phosphotriester derivatives of... |
| US-5,688,957 |
[(3"-thioxacyclohex-1"-enyl)]-but-3'-ene-1'-ynyl]aryl and
... Compounds of the formula ##STR1## where R.sub.1, R.sub.2, R.sub.3, and R.sub.4 independently are H or lower alkyl of 1 to 10 carbons; R.sub.5 is lower alkyl... |
| US-5,688,956 |
Method for preparing N-methyl 2-(3-pyridyl)
(1R,2R)-2-tetrahydrothiopyrancarbothioamide-1-oxide The present invention relates to a process for the preparation of (1R,2R)-N-methyl -2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide of formula: ... |
| US-5,688,955 |
Kappa agonist compounds and pharmaceutical formulations thereof Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics are provided. The compounds of formulae I, II, III... |
| US-5,688,954 |
Process for the preparation of substituted thiopyran-1-oxides A process is described for the preparation of a compound of formula (IX) from 4-hydroxybutyl 3-pyridyl ketone. The compound of formula (IX) is an intermediate... |
| US-5,688,953 |
Process for the preparation of 3,3,5-trichloroglutarimide 3,3,5-Trichloroglutarimide is prepared by combining 4-cyano-2,2,4-trichlorobutanoyl chloride with water in an inert organic solvent at a temperature between... |
| US-5,688,952 |
[(Benzodioxan benzofuran or benzopyran) alkylamino]alkyl substituted
guanidines The present invention is concerned with vasoconstricive [(benzodioxan, benzofuran or benzopyran)alkylamino]alkyl substituted guanidines having the formula ... |
| US-5,688,951 |
Hindered amine light stabilizer New N-substituted piperidines useful as light stabilizers in synthetic resins are disclosed. They are 1-(2,7-octadienyl)-2,2,6,6-tetraalkylpiperidines wherein... |
| US-5,688,950 |
Tricyclic aminoalkylcarboxamides; novel dopamine D.sub.3 receptor
subtype specific ligands Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof wherein: R1-R.sub.4 represent organic or... |
| US-5,688,949 |
Pyrazolo[1,5-A]pyrimidine derivatives and anti-inflammatory agent
containing the same Pyrazolo[1,5-a]pyrimidine derivatives of the formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H, carboxyl, lower alkoxy-carbonyl, phenyl,... |
| US-5,688,948 |
Process for isomerizing acyclic nucleosides and process for separating
purine nucleosides Herein is disclosed a novel and industrially advantageous process for synthesizing acyclic nucleosides such as acyclovir and ganciclovir from ribonucleosides,... |
| US-5,688,947 |
Production of purines via reductive formylation In order to produce a purine of the general formula (I), ##STR1## in which R.sup.1 and R.sup.2 can be the same or different and denote H, OH, SH, NH.sub.2,... |
| US-5,688,946 |
Amino acid derivatives having renin inhibiting activity The compounds of the formula ##STR1## in the form of optically pure diastereomers, mixtures of diastereomers, diastereomeric racemates or mixtures of... |
| US-5,688,945 |
Compounds The present invention relates to novel derivatives of 3-hydroxyanthranilic acid, 3-HANA, of the general formula I ##STR1## wherein R.sup.1 and R.sup.2 are... |
| US-5,688,944 |
Carbamazepine derivatives The present invention provides a novel carbamazepine hydrazide compound suitable for covalent attachment to a polymer particle reagent, having the general... |
| US-5,688,943 |
Benzodiazepine derivatives useful as CCK-receptor antagonists This invention relates to benzodiazepine derivatives which are useful as drugs exhibiting antagonism at the gastrin and/or CCK-B receptor, and to their production. |
| US-5,688,942 |
Process for preparing 2-isocephem derivatives A process for preparing a 2-isocephem derivative characterized in that a thioacetic acid derivative which itself is basic or a mixture of a base and a thioacetic... |
| US-5,688,941 |
Methods of making conjugated 4' desmethyl nucleoside analog compounds Tetrahydrofuranyl compounds are provided that are functionalized to include pendant conjugate groups, and which are useful in diagnostic assays and as research... |
| US-5,688,940 |
Linker for immobilization, modification and subsequent release of
oligomers with a terminal hydroxyl group The invention is a method which allows the attachment of an alcohol to a substrate by the use of which chemical and/or enzymatic transformations of the alcohol... |
| US-5,688,939 |
Plant adenylosuccinate synthetase and DNA coding therefor The present invention provides novel plant DNA sequences coding for native adenylosuccinate synthetase (ADSS). Methods for using the complete or partial ADSS... |
| US-5,688,938 |
Calcium receptor-active molecules The present invention relates to the different roles inorganic ion receptors have in cellular and body processes. The present invention features: (1) molecules... |
| US-5,688,936 |
Vesicle membrane transport proteins Complete cDNA and amino acid sequences are disclosed for rat adrenal-specific and brain-specific transport protein, as well as for human brain-specific transport... |
| US-5,688,935 |
Nucleic acid ligands of tissue target This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex... |
| US-5,688,933 |
Preparation of biologically active compounds from substantially pure
enantiomers of... Lactams of 1-amino-3-carboxylic acid cyclic compounds are provided in enantiomeric form, together with an enantiomer of the corresponding ring-opened amino-acid... |
| US-5,688,931 |
Polysaccharide derivatives and drug carriers A novel polysaccharide derivative, a drug carrier comprising a novel polysaccharide derivative, and a drug complex are disclosed. The polysaccharide derivative... |
| US-5,688,930 |
Process for the preparation of surface active agents using wheat
by-products and their applications Processes for preparing mixtures of alkyl pentosides from wheat by-products, such as wheat bran, wheat fibre or wheat straw are provided. The resulting mixtures... |
| US-5,688,929 |
Surface active galacturonic acid derivatives The galacturonic acid derivatives of formula: ##STR1## R1 being a linear or branched alkyl having 2 to 22 carbon atoms, R being: ##STR2## for which... |
| US-5,688,928 |
Phenylboronic acid complexing reagents derived from aminosalicylic acid The present invention relates to a novel class of phenylboronic acid complexing reagents useful for the preparation of bioconjugates, and the method of making... |
| US-5,688,927 |
Macrophage derived chemokine The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived C--C chemokine designated MDC. Also... |
| US-5,688,926 |
Process of preparing etoposide phosphate and etoposide Etoposide phosphate is prepared by coupling dibenzyl 4'-demethyl-4-epipodophyllotoxin-4'-phosphate with ... |
| US-5,688,925 |
Intermediates for the preparation of demethylepipodophyllotoxin Demethylepipodophyllotoxin-.beta.-glucosides are prepared by allowing demethylepipodophyllotoxin to react with a 2,3-di-O-ester of a ... |
| US-5,688,924 |
Derivatives of 12,13-Epoxy-tylosin and processes of manufacture thereof The invention relates to derivatives of 12,13-epoxy-tylosin, the novel seynthetic antibiotics from tylosin group and the methods of their preparation. According... |
| US-5,688,923 |
Pectin fibers A polyvalent cation crosslinked pectin fiber composition is composed of a calcium sensitive low methoxyl pectin with a degree of esterification (DE) of less than... |
| US-5,688,922 |
Substituted fucopyranosides 2-Chloromethyl-3-(tri-O-benzyl-.alpha.-L-C-fucopyranoside)-1-propene and methods of making the same are described. Methods of combining this substituted... |
| US-5,688,921 |
Reagents and methods for the detection and qualification of thyroxine in
fluid samples Immunoassay methods and reagents for the specific quantification of thyroxine in a test sample are disclosed employing antibodies prepared with thyroxine... |
| US-5,688,920 |
Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD
and uses therefor Disclosed and claimed are nucleotides for genes encoding the canine herpesvirus (CHV) gB, gC and gD homologues. These genes encode polypeptides of 879, 459 and... |
| US-5,688,919 |
Process for the purification of factor XIII, monoclonal antibodies
against factor XIIIA, the preparation and... A process for the purification of factor XIII or XIIIA by immunoaffinity chromatography, monoclonal antibodies against factor XIIIA, the preparation thereof and... |
| US-5,688,918 |
p53as protein and antibody therefor The invention comprises plasmids and viral vectors containing an animal p53as cDNA sequence. A portion of the p53as sequence may be identified to a position of... |
| US-5,688,917 |
Process for functional expression of the para cation channel DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active... |
| US-5,688,916 |
Human cell adhesion molecule A human brain glycoprotein homologous to the mouse F3 and the chicken contactin/F11 adhesion molecules, nucleic acid sequences encoding the human brain... |
| US-5,688,915 |
Long term maintenance of lymphocytes in vitro Long term culture of resting T lymphocytes. The present invention provides methods and compositions for maintaining resting, mature T lymphocytes (cells) for... |
| US-5,688,914 |
Composition containing a B epitope of the envelope glycoprotein of a
retrovirus and a T epitope of another... Compositions comprise one or more B epitopes of the envelope glycoprotein of a retrovirus and one or more T epitopes of the envelope glycoprotein from a distinct... |
| US-5,688,913 |
CS-1 peptidomimetics, compositions and methods of using the same The present invention contemplates a peptide that inhibits the binding between the VLA-4 receptor expressed on inflammatory leukocytes and the fibronectin CS-1... |